Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tibetree Pain-Relieving Plaster is a topical herbal analgesic patch formulated with 1% camphor and a proprietary blend of Tibetan medicinal herbs, including *Zanthoxylum bungeanum*, *Lamiophlomis rotate*, and *Curcuma longa*. It is manufactured by Tibet Cheezheng Tibetan Medicine and is available over-the-counter for the temporary relief of minor musculoskeletal aches and pains. The product is currently being investigated in a Phase II clinical trial (NCT04916249) led by Memorial Sloan Kettering Cancer Center to evaluate its efficacy in managing chronic musculoskeletal pain specifically in cancer survivors in remission. Its therapeutic effects are attributed to anti-inflammatory and antinociceptive properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tibetree Pain-Relieving Plaster (Memorial Sloan Kettering Cancer Center).